EU fines Teva over delaying cheap sleep disorder drug
European Union regulators fined Israeli drug-maker Teva on Thursday for colluding to delay a cheaper generic version of modafinil, a blockbuster sleep disorder drug.
Nov 26, 2020
0
4
European Union regulators fined Israeli drug-maker Teva on Thursday for colluding to delay a cheaper generic version of modafinil, a blockbuster sleep disorder drug.
Nov 26, 2020
0
4
The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers.
Apr 1, 2013
0
0
A comparison of two of the most disparate approved generic antiepileptic drugs found minimal differences when compared under rigorous testing procedures in people with epilepsy, according to research presented by a University ...
Dec 10, 2014
0
0
Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).
Nov 11, 2019
0
1
In a win for consumers, the California Supreme Court ruled Thursday that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash ...
May 7, 2015
0
10
(HealthDay)—The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration.
Jun 18, 2018
0
0
Drugmaker Pfizer Inc. said Tuesday that a new patent on one of its top drugs, anti-inflammatory painkiller Celebrex, extends its U.S. patent protection by 18 months, potentially bringing the company a few billion dollars ...
Mar 5, 2013
0
0
(HealthDay)—Seeking to ease potentially dangerous shortages of a key cancer drug, the U.S. Food and Drug Administration on Monday announced it had fast-tracked the approval of the first generic form of one such medication, ...
Feb 4, 2013
0
0
Families across the U.S. are scrambling to feed their babies as formula becomes less and less available.
May 11, 2022
0
4
Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix.
Jun 12, 2013
0
0